Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Tofacitinib | 0.3 | uM | 2 | MIP-1B | 61.0 | 83 | ||||
RA2159 | 2 | MIP-1B | 62.0 | 85 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | MIP-1B | 48.0 | 66 | ||||
N2645 | 2 | MIP-1B | 63.0 | 80 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | MIP-1B | 67.0 | 63 | ||||
RA2708 | 2 | MIP-1B | 63.0 | 77 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 94.0 | 58 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 105.0 | 88 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 90.0 | 96 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 98.0 | 81 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 91.0 | 91 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 105.0 | 76 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 126.0 | 46 | |
RA2159 | TNF-a | 100 | ng/mL | 2 | MIP-1B | 132.0 | 65 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 101.5 | 58 | |
N2645 | TNF-a | 100 | ng/mL | 2 | MIP-1B | 103.0 | 83 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 118.5 | 56 | |
RA2708 | TNF-a | 100 | ng/mL | 2 | MIP-1B | 109.0 | 56 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 55.0 | 72 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 59.0 | 86 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 56.0 | 75 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 63.0 | 74 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 60.0 | 81 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 67.0 | 67 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 178.5 | 54 |